Farsoon(SH:688433)2025-04-28 10:35Financial Performance - The company's operating revenue for Q1 2025 was CNY 126,019,834.83, representing a year-on-year increase of 1.32% compared to CNY 124,375,418.71 in the same period last year[4]. - The net profit attributable to shareholders decreased significantly by 94.63%, amounting to CNY 1,410,133.00, down from CNY 26,279,077.90 in the previous year[4]. - The net profit attributable to shareholders after deducting non-recurring gains and losses also saw a decline of 94.85%, totaling CNY 1,250,928.74 compared to CNY 24,296,842.30 last year[4]. - The basic and diluted earnings per share were both CNY 0.0034, reflecting a decrease of 94.65% compared to CNY 0.0635 in the same period last year[4]. - The weighted average return on equity decreased by 1.28 percentage points to 0.07% from 1.35% in the previous year[4]. - The company reported a comprehensive income total of CNY 1,858,445.30 for Q1 2025, compared to CNY 25,998,268.80 in Q1 2024[21]. Cash Flow and Liquidity - The net cash flow from operating activities was negative at CNY -44,939,293.38, an improvement from CNY -54,768,127.58 in the previous year[4]. - Cash received from sales of goods and services in Q1 2025 was CNY 97,328,291.69, down from CNY 103,672,268.58 in Q1 2024[23]. - The net cash flow from investment activities was -8,395,127.96, an improvement from -40,151,017.92 in the previous period[24]. - The net increase in cash and cash equivalents was -52,120,065.14, compared to -95,699,989.54 in the previous period, showing a reduction in cash outflow[25]. - The ending balance of cash and cash equivalents was 812,987,020.49, down from 1,120,835,944.58 in the previous period[25]. Research and Development - Research and development (R&D) expenses increased by 49.48% to CNY 24,308,920.10, up from CNY 16,262,727.17, indicating a strong commitment to innovation[4]. - The proportion of R&D expenses to operating revenue rose by 6.21 percentage points to 19.29% from 13.08%[5]. - Research and development expenses increased to CNY 24,308,920.10 in Q1 2025, up 49.49% from CNY 16,262,727.17 in Q1 2024[19]. Assets and Liabilities - The total assets at the end of the reporting period were CNY 2,448,141,980.93, a decrease of 2.23% from CNY 2,503,997,557.15 at the end of the previous year[5]. - Current assets decreased from CNY 1,690,144,152.75 to CNY 1,552,276,888.21, reflecting a decline of approximately 8.2%[14]. - Cash and cash equivalents were reported at CNY 813,018,937.49, down from CNY 865,139,002.63, indicating a decrease of about 6.0%[13]. - The company's total liabilities decreased to CNY 491,234,793.58 in Q1 2025 from CNY 560,301,581.99 in Q1 2024[16]. - The total liabilities and equity structure remains stable, with a focus on maintaining liquidity and operational efficiency[12]. Future Outlook - The company is actively monitoring market conditions for potential expansion opportunities and strategic partnerships[12]. - Future outlook includes a commitment to innovation and technology development to enhance competitive positioning in the market[12].